FindTrial
Sign In

Effects of glucose metabolism disorder and rebalance on pulmonary function and inflammation in patients with COPD

Effects of glucose metabolism disorder and rebalance on pulmonary function and inflammation in patients with COPD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073627
Enrollment
Unknown
Registered
2023-07-17
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

diabetes:none
Non-diabetic:none

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Age > 40. 2. In line with the diagnostic criteria of COPD: FEV1/FVC<70% after bronchodilation test;4. Complete clinical information records. 5. Diabetes diagnosis criteria: medical history, fasting blood glucose, glycosylated hemoglobin or OGTT, etc.

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical data 2. FEV1/FVC=70% after treatment. 3. Age < 40. 4. Abnormal mental state. 5. History of drug abuse and drug use. 6. Pregnancy and lactation. 6. Participating in other clinical intervention experiments.

Design outcomes

Primary

MeasureTime frame
Respiratory function;—

Secondary

MeasureTime frame
Nitric oxide;blood glucose;BMI;CRP;Blood routine;—

Countries

China

Contacts

Public ContactYi Liu

Shandong Provincial Hospital

yiliu_sdu@163.com+86 189 5396 1613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026